The disconnect between Rheinmetall’s operational momentum and its stock market performance has rarely been starker. The German defence group has just secured a blockbuster drone contract worth billions from the Bundeswehr, yet its shares have slumped to their lowest level in a year — a divergence that is leaving analysts scratching their heads and investors nursing losses.
Bundeswehr’s Loitering Munition Deal
On 22 April, the Federal Office of Bundeswehr Equipment signed a framework agreement for the FV-014 loitering munition, with a coverage volume of approximately €2.4 billion. The initial call-off covers around 2,500 units at a gross cost of roughly €300 million, with the option for the German military to order a five-figure quantity in total. The parliamentary budget committee had given its green light on 15 April.
The FV-014, internally designated “Raider,” is an electrically powered drone in the 20-kilogram class. It carries a 4-kilogram warhead, has a range of up to 100 kilometres, and can loiter for 70 minutes. The system operates effectively even in GPS-denied environments and supports swarm operations. Rheinmetall manufactures it entirely within the EU. Qualification is expected by September 2026, with initial deliveries slated for the first half of 2027.
This marks the third loitering munition contract awarded by the Bundeswehr this year alone. In February, the budget committee approved framework agreements with Helsing and STARK, each with initial call-offs around €270 million. The FV-014 systems are intended to equip, among others, Panzerbrigade 45 in Lithuania from 2027.
Share Price Pain Deepens
Despite the contract bonanza, the market has taken a distinctly bearish view. Rheinmetall’s stock closed on Friday at €1,321.20 — a new 52-week trough. The decline accelerated sharply during the session, with the share price shedding nearly five percent in a single day to hit €1,341.20, before settling lower. On a weekly basis, the cumulative loss now exceeds ten percent.
Since the start of 2026, the shares have lost roughly 17.5 percent of their value. From the all-time high of nearly €2,000 reached in September 2025, the stock has surrendered more than a third of its market capitalisation.
The technical picture has deteriorated markedly. The gap to the 200-day moving average has widened to around 20 percent. Chart watchers point to a head-and-shoulders formation and a so-called death cross — both patterns that tend to generate additional selling pressure.
Should investors sell immediately? Or is it worth buying Rheinmetall?
Production Ramp-Up and Cost Benefits
While the share price languishes, Rheinmetall’s management has been projecting strength on the operational front. Speaking at the Hannover Messe, chief executive Armin Papperger emphasised the defence industry’s ability to scale production rapidly. Output of artillery munitions has increased more than tenfold since the start of Russia’s full-scale invasion of Ukraine. The company has taken significant pre-financing risks to achieve this, with Papperger noting that initial investments were agreed “by a handshake” even before formal contracts were signed.
As volumes from Germany and Europe continue to rise, the board expects unit costs to fall. For artillery munitions, these economies of scale are already measurable. The CEO’s appearance at the trade fair was not without disruption — security personnel had to remove several protesters who were chanting against arms production.
Analyst Optimism Versus Market Reality
For the full year 2026, Rheinmetall is targeting revenue of between €14.0 billion and €14.5 billion — representing growth of 40 to 45 percent compared with the prior year. Crucially, more than 90 percent of this target is already covered by existing orders. At the end of 2025, the order backlog stood at nearly €64 billion.
This gulf between business fundamentals and share price performance has drawn attention from the analyst community. Jefferies recently lifted its price target to €2,220 and reaffirmed a “Buy” rating, arguing that land defence stocks have become particularly attractive after the sector’s recent correction. Bernstein Research maintains an “Outperform” rating with a €2,050 target, while Berenberg sees buying opportunity at €2,100.
The market, however, remains unconvinced. The question is whether the drone contract alone can restore investor confidence — or whether the market will demand hard evidence of financial progress.
Key Catalysts Ahead
The next major test arrives on 7 May, when Rheinmetall publishes its first-quarter results for 2026. Investors will be scrutinising order intake trends and margin development with particular intensity. Five days later, the annual general meeting will provide a platform for management to explain the widening gap between operational strength and technical weakness in the share price.
Until then, the defence group finds itself in an unusual position: sitting on a record order book, winning billion-euro contracts, and yet watching its stock trade at levels not seen in 12 months.
Ad
Rheinmetall Stock: Buy or Sell?! New Rheinmetall Analysis from April 25 delivers the answer:
The latest Rheinmetall figures speak for themselves: Urgent action needed for Rheinmetall investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
Rheinmetall: Buy or sell? Read more here...
